Effect of Vit C Supplement on Fasting Blood Glucose and Plasma Lipid Level in Type II Diabetic Patients
DOI:
https://doi.org/10.22100/jkh.v3i1.203Keywords:
Diabetes type II Vit C Fasting blood glucose, Lipid Glycosylated HemoglobinAbstract
Introduction: Diabetic people are more at risk of diseases such as vascular, kidneys and eye diseases, compared with normal people. Since Vit C competitively replaces glucose in most chemical reactions; so inhibit on non enzymatic glycosylation such as hemoglobin and lipoproteins, it seems that Vit C can be effective to prevent diabetic complications .In this study effect of Vit C supplements on blood sugar and fats level in type II diabetic patients was investigated.
Methods: This study was conducted as a clinical trial using paired random sampling on 136 type II diabetic patients. At first, the patients weights, age, type of diet were recorded .Then their fasting blood glucose (FBS), glycosylated hemoglobin (HbAIC), Cholesterol, triglyceride, HDL and LDL were measured. After that the patients were divided in two randomized groups. The first group (control) was subject of administration of Vit C supplement (1250 mg, 5 times a day, for a period of 3 months) and the second group received placebo. Data were analyzed by paired t- test and SPSS Software.
Results: In this study most of patients were women (62.2% of control group and 64.7% of placebo group). The mean age between the control group and placebo group were reported 51.2 ± 6.8 and 50.37± 9.71 years respectively. At the end of study , after 3 months of administration of Vit C supplement to control group, the mean concentration of FBS, LDL triglyceride Cholesterol and glycosylated hemoglobin has been reduced significantly with respect to the placebo group and the mean value of HDL has been increased as well.
Conclusion: The finding shows that Vit C supplements might reduce the amount of glucose, lipids and glycosylated hemoglobin in patients with type 2 diabetes. Therefore, its consumption in diabetic patients can be recommended and as a result patient complications will be significantly reduced.
References
Marion JF, Medical nutrition therapy for diabetes mellitus and hyperglycemia of nondiabetic origin. In: Mahan LK, Escott-stump S, editors. Krauses food nutrition and diet therapy. 10th ed. Philadelphia pennsylavania: W.B. Saunders Company; 2004.p.742-780.
Hjelm k, Mufunda E, Nambozi G, Kemp J. Preparing nurses to face the pandemic of diabetes meilitus: A literature review. J Adv Nurs 2003; 4(5): 424-34.
Wild S, Roglic G, Green AS. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
Azizi F, Janghorbani M, Hatami H. Epidemiology and control of common disorders in Iran. Tehran: Khosravi press; 2004.
Larijani B, Abolhasani F, Tabatabayi O, Mohajerani MR. Frequency of diabetes type II in Iran, 1380. Iranian Journal of Diabetes and Lipid Disorders 2005; 4(3): 83-85.
Esteghamati A, Gouya M, Abbasi M, Delavari M, Alikhani A, Alaedini S, et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National survey of risk factors for non-communicable diseases of Iran. Diabetes Care 2008; 31(1): 96-98.
Brownlee M, Cerami A, Vlassara H. Advanced products of non–enzymatic glycosylation. In: Kahn CP, Weir, editors. Joslin’ S diabetes mellitus. Philadelphia: lea and Febiger; 1994. p.631-47.
Shoff SM, Mares-Perlman JA, Cruickshanks KJ, Klein R, Klein BE, Ritter LL. G Glycosylated hemoglobin concentrations and vitamin E, vitamin C, and beta-carotene intake in diabetic and nondiabetic older adults. Am J Clin Nutr 1993; 58(3): 412-6.
Waezulikova I, Krahulec B, Carsky J, Orszaghova Z. Effect of vitamin C and E on non enzymatic glycation and physicochemical properties of isolated erythrocyte membranes in diabetic patients. J Bratisl Lek Listy 2000; 101: 752-6.
Farvid MS. Effects of supplementation with vitamin C or E on blood suger and lipids of diabetic patients[dissertantion]. Tehran: Shaheed Beheshti University of Medical Sciences; 1998.
Darvish Moghaddam S, Moshtaghi Kashanian GH, Hayatbakhsh M, Mehdipour A. Effect of pharmacologic doses of vitamin C on glycosylated hemoglobin in type 2 diabetic patients. IJEM 2003; 4 (1): 15-21. Persian.
Erikson J, Kohvakka A. Magnesium and ascorbic acid supplementation in diabetes mellitus. Ann Nutr Metab 1995; 39: 217-23.
- Forghani B, Goharian V, Kassayian N, Amini M. The effect of vitamin C supplements on serum lipoprotein levels in NIDDM patients. J M C Isfahan Univ 2001; 2: 95-100. Persian.
Perry RC, Shankar RR, Fineberg N, McGill J, Baron AD. HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose. Diabetes Care 2001; 24: 465-471.
Jesudason DR, Dunstan K, Leong D, Wittert GA. Macrovascular risk and diagnostic criteria for type 2 diabetes implications for the use of FPG and HbA1c for cost-effective screening. Diabetes Care 2003; 26: 485-490.
Padayatty SJ, Katz A, Wang Y, Eck P, Kwon O, Less JH, et al. Vitamin C as an antioxidant: Evaluation of its role in disease prevention. J Am Coll Nutr 2003; 22(1): 18-35.
Hillstrom RJ, Yacapin-Ammons AK, Lynch SM. Vitamin C inhibits lipid oxidation in human HDL. J Nutr 2003; 133:3047-3051.
Hallfrisch J, Singh VN ,Muller DC, Baldwin H. Bannon ME, Andres R. High plasma vitamin C associated with high plasma HDL- and HDL2 cholesterol. Am J Clin Nutr 1994; 60(1): 100-5.
Forghani B, Goharian V, Kasaeeian N, Amini M. The influence of supplemental vitamin C on glycosylated hemoglobin in patients with type 2 diabetes. mellitus. Int J Endocrinol Metab 2003; 2:67-70.
Afkhami-Ardekani M, Vahidi AR, Borjian L, Borjian L. Effect of vitamin C supplement on glycosylated hemoglobin in patients with type 2 diabetes. J Shah Sad Univ 2003; 10: 15-8. Persian.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
